Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon

Announces Receipt of Positive Formal FDA Feedback via the Q-Submission Program


Substantially reduces the anticipated time and cost needed to receive a PMA

... | March 28, 2023

Related Keywords

Minnesota ,United States ,Eden Prairie ,Gary Maharaj ,Kenneth Rosenfield ,Drug Administration ,Nasdaq ,Surmodics Inc ,Fda Program ,Transcend ,Submission Issue Request ,Submission Program ,Submission Issue Meeting ,Chief Executive Officer ,Surmodics ,Nc Stock Exchange ,News ,Information ,Press Release ,Nnounces ,Receipt ,F ,Positive ,Normal ,Fda ,Feedback ,Cia ,The ,Educes ,Nticipated ,Dime ,End ,Most ,Eeded ,O ,Eceive Srdx Us8688731004 ,